Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sara Manzano Figueroa"'
Publikováno v:
Cancer Research. 81:2784-2784
Introduction: In recent years, the detection of RNA molecules has become increasingly important for the analysis of the physiological status of cells within tissues. This has complemented the established immunohistochemistry (IHC)/immunofluorescent (
Publikováno v:
Cancer Research. 81:457-457
Introduction In the 2016 World Health Organization Central Nervous System Tumor Classification, diffuse gliomas were reclassified to include astrocytic tumors (grade II and III), oligodendrogliomas (grade II and III), and grade IV glioblastomas with
Autor:
Hakon Hakonarson, Paloma Bragado, Jingchun Qu, Renata Pellegrino, Hui‐Qi Qu, Maria Rodrigo Faus, Alvaro Gutierrez-Uzquiza, Almudena Porras, Sara Manzano Figueroa
Publikováno v:
Cancer Research. 81:2310-2310
Background: Thanks to the availability of new biomarkers, Prostate cancer (PCa) can now be diagnosed earlier and, as a result, PCa patients have a high 5-year survival rate. Nonetheless, the situation changes completely for patients who develop metas
Publikováno v:
Cancer Research. 78:3860-3860
When mouse, rat, and rabbit antibodies are used, consideration of the target tissue is of critical importance. Endogenous IgGs present in tissues pose significant challenges to interpretation. When a species conflict exists for the antibody and the t
Publikováno v:
Cancer Research. 78:1026-1026
Introduction: The recent success of checkpoint inhibitor therapies in clinical oncology practice has generated overwhelming enthusiasm for immunotherapeutics. Recent studies have suggested that patients with mismatch repair deficient (dMMR)/microsate
Publikováno v:
Cancer Research. 77:3831-3831
Introduction When a mouse or monoclonal antibody is desired for immunohistochemical detection on mouse tissues, the anti-mouse secondary antibody will also bind to endogenous mouse IgG in the tissue and may produce unwanted background staining. In th